CS1
CS1 is a potent DNA Topo II α inhibitor. CS1 displays broad-spectrum in vitro antitumor effects, low toxicity in vivo and potential anti-multidrug resistance capabilities. CS1 leads to DNA damage, cell cycle arrest at G2/M phase and apoptosis.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1448009-94-6
- 화학식: C16H12O3
- 분자량:252.26
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
제품 설명
IC50 & Target
|
topoisomerase II alpha |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
11.5 μM
Compound: 1
|
Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay
|
[PMID: 25240702] |
| HeLa | IC50 |
4.6 μM
Compound: 1
|
Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay
Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay
|
[PMID: 25240702] |
| MDA-MB-231 | IC50 |
4.3 μM
Compound: 1
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay
|
[PMID: 25240702] |
| MDA-MB-231 | IC50 |
4.3 μM
Compound: CS1
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by CCK8 assay
|
[PMID: 36063665] |
In Vitro
CS1 shows cytotoxicity with IC50 values of 16.92 and 18.88 µM for MCF-7 and MCF7/ADR cells, respectively[1]
.
CS1 (10, 50, 100 µM) inhibits the activity of topoisomerase II α (Topo IIα)[1].
CS1 (0-20 µM) shows antiproliferation activity in cancer cells[1].
CS1 (2.5, 5, 10 µM) induces cell cycle arrest at the G2/M phase[1].
CS1 (2.5, 5, 10 µM) induces cell apoptosis[1].
CS1 (5, 10, 15 µM; 24 h) induces DNA breaks in MDA-MB-231 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Five-week-old female athymic nude mice (BALB/c-nu)[1]
-
Dosage:20 mg/kg
-
Administration:i.v., every other day for two weeks
-
Result:Showed antitumor effects.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1448009-94-6
-
분자량 252.26
-
화학식 C16H12O3
-
SMILES
OC1=CC=C(C2=CC=C3C=C(O)C=CC3=C2)C=C1O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
-
Data Sheet (270 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)